Literature DB >> 1698662

Palliative surgery for brain metastases of malignant melanoma.

S Oredsson1, C Ingvar, L G Strömblad, P E Jönsson.   

Abstract

Forty patients with melanoma brain metastases were treated by surgery. Single brain metastases were found in 32 cases and multiple in eight. The most frequent tumor location was the frontal and frontoparietal lobes. Neurological improvement was observed in 25 patients and surgical mortality rate was less than 5%. The median survival time for all patients was 8 months. When patients with multiple cerebral metastases were excluded the median survival time was 13 months. The 3- and 5-year survival was 25% and 15%, respectively. Seventeen patients with extracerebral metastases received treatment and were without known extracerebral tumor at the time of brain metastases diagnosis. These patients had a median survival time that did not significantly differ from those without occurrence of extracerebral metastases. Quality of life as judged by Karnofsky index was improved after surgery and maintained on an acceptable level for the remaining time of survival.

Entities:  

Mesh:

Year:  1990        PMID: 1698662

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  4 in total

Review 1.  Surgical treatment of metastatic brain tumors.

Authors:  R Sawaya; B L Ligon; A K Bindal; R K Bindal; K R Hess
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

Review 2.  Management of metastatic brain tumors.

Authors:  R Sawaya; B L Ligon; R K Bindal
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

3.  The role of adjuvant radiation and multiple resection within the surgical management of brain metastases.

Authors:  F Weber; A Riedel; W Köning; J Menzel
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

4.  Simultaneous surgical resections of two distant metastatic malignant melanoma lesions--case report.

Authors:  Takafumi Tanei; Norimoto Nakahara; Shigenori Takebayashi; Masaki Hirano; Toshihiko Wakabayashi
Journal:  Nagoya J Med Sci       Date:  2012-02       Impact factor: 1.131

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.